Editorial
Emerging Viral Resistance: Dealing with Uncertainty in Human Immunodeficiency Virus Chemoprophylaxis
Abstract
The therapeutic decision, a good example for choice theory, can become a hard task when many options exist in the absence of well-defined criteria to support it. The difficulties are greater in infectious diseases, where the treatment or chemoprophylaxis often needs to be initiated in the absence of resistance data concerning the antimicrobial susceptibility of etiological agent(s). This could result in suboptimal therapy increasing the risk of failure due to lack of activity against the etiological agent, or excessive therapy promoting an unnecessary risk of germ resistance.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.